These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6814466)

  • 21. [Results of 100 observations on the activity of 1035 M.D. in various neuro-psychiatric disorders due to cerebrovascular insufficiency].
    Digo R; Bellot JC
    Encephale; 1969; 58(3):267-82. PubMed ID: 5378185
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine].
    Cosmi F; Caresia L; Panebianco G
    Clin Ter; 1986 Feb; 116(3):213-20. PubMed ID: 3698528
    [No Abstract]   [Full Text] [Related]  

  • 23. [Vincamine in the therapy of cerebral vascular diseases in the aged].
    De Candia O; Bartolucci E; Mancinella A; Baghiris D
    Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences with the myotonolytic chlormezanone].
    Krüger E; Rabending G; Koch RD
    Psychiatr Neurol Med Psychol (Leipz); 1966 Apr; 18(4):155-8. PubMed ID: 4861472
    [No Abstract]   [Full Text] [Related]  

  • 25. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
    Dartigues JF; Père JJ
    Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders.
    Albizzati MG; Bassi S; Sbacchi M; Frattola L
    Br J Clin Pract Suppl; 1984; 34():69-73. PubMed ID: 6430327
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical uses of benzodiazepines.
    Hollister LE; Müller-Oerlinghausen B; Rickels K; Shader RI
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 1):1S-169S. PubMed ID: 7905883
    [No Abstract]   [Full Text] [Related]  

  • 28. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
    Piguet PV; Zoufal Z
    Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
    [No Abstract]   [Full Text] [Related]  

  • 29. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
    Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D
    G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of amantadine on the state of consciousness in diffuse cerebral psychosyndromes caused by vascular disorders].
    Vitetta M
    Minerva Med; 1971 Oct; 62(82):3984-6. PubMed ID: 5125059
    [No Abstract]   [Full Text] [Related]  

  • 31. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
    Jansen W; Bruckner GW; Jansen P
    J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinomimetic treatment of neuropsychiatric disorders: a review of recent developments.
    Davis KL
    Mt Sinai J Med; 1979; 46(5):455-9. PubMed ID: 395438
    [No Abstract]   [Full Text] [Related]  

  • 33. Psychopharmacology of aging: current trends.
    Sathananthan GL; Ferris S; Gershon S
    Curr Dev Psychopharmacol; 1977; 4():249-64. PubMed ID: 23249
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical studies with Glaziovin in the fields of internal medicine and neuropsychiatry].
    Höffkes H; Leube H
    Med Monatsschr; 1975 Jul; 29(7):321-5. PubMed ID: 1105121
    [No Abstract]   [Full Text] [Related]  

  • 35. Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders.
    Gold SM; Voskuhl RR
    Curr Opin Investig Drugs; 2006 Jul; 7(7):625-30. PubMed ID: 16869115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Papaveroline in mental disorders caused by a deficit of non-focalized cerebral circulation].
    Pala A; Alleva PM
    Clin Ter; 1981 Jan; 96(1):39-44. PubMed ID: 7237948
    [No Abstract]   [Full Text] [Related]  

  • 37. [The use of Ergocomb in symptoms of cerebrovascular insufficiency].
    Pöthig D; Sauer I; Hansen H; Weidnitzer M
    Z Alternsforsch; 1983; 38(6):443-9. PubMed ID: 6659572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dihydroergotoxine mesylate in chronic cerebrovascular insufficiency: spectral EEG analysis and neuropsychological correlates].
    Moglia A; Bono G; Sinforiani E; Alfonsi E; Zandrini C; Pistarini C; Arrigo A; Franch F
    Farmaco Prat; 1983 Feb; 38(2):97-102. PubMed ID: 6832350
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of redergin in patients with vertebrobasilar syndrome].
    Pashchuk AIu; Kudimov SA; Kotul'skiĭ IV; Gruntovskiĭ GKh
    Ortop Travmatol Protez; 1983 Dec; (12):25-8. PubMed ID: 6142444
    [No Abstract]   [Full Text] [Related]  

  • 40. Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders.
    Assisi A; Banzi R; Buonocore C; Capasso F; Di Muzio V; Michelacci F; Renzo D; Tafuri G; Trotta F; Vitocolonna M; Garattini S
    Int Clin Psychopharmacol; 2006 Nov; 21(6):319-36. PubMed ID: 17012979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.